1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage

Amiram Ravid*, Dafna Rocker, Arthur Machlenkin, Carmela Rotem, Ayala Hochman, Gania Kessler-Icekson, Uri A. Liberman, Ruth Koren

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of '1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage'. Together they form a unique fingerprint.

Medicine & Life Sciences